Cubst Pharma Shares Slipped After Narrowing Sales Expectations (CBST)
Fri. October 16, 2009; Posted: 01:11 PM
Oct 16, 2009 (SmarTrend(R) News Watch via COMTEX) --
CBST |
Quote |
Chart |
News |
PowerRating -- 10/16/2009 - Cubist Pharmaceuticals Inc. (NASDAQ:CBST) shares slipped 3.6% Friday after the company narrowed its expectations for sales of its antibiotic Cubicin. The company now expects U.S. sales of the drug to be between $520 million to $525 milion for 2009, up from the previous forecast of $520 million to $540 million. The company beat consensus estimates for both profit and revenue when it reported Q3 results on Thursday.
Write to Chip Brian at cbrian@tradethetrend.com
---------------------------------------------------------------------------------------------
SmarTrend analyzes over 5,000 securities simultaneously throughout the trading day and provides its subscribers with trend change alerts in real time. To get a free trial of our trading calls and maximize your trading results, please visit http://www.TradeTheTrend.com.
Get exclusive, actionable insight into how the market is expected to trend prior to market open with our free morning newsletter. Sign up at: http://www.TradeTheTrend.com/signup.html
For full details on Cubist Pharmaceuticals (CBST)
click here. Cubist Pharmaceuticals (CBST) has Short Term PowerRatings of 5. Details on Cubist Pharmaceuticals (CBST) Short Term PowerRatings is available at
This Link.
More News:
Market Updates |
Stock Alerts |
All Trading News |
Stock Index